Lymphoma - Hodgkin - Childhood


Dr. Tony Talebi discusses the Treatment of Stage 1-2 Hodgkin Lymphoma with Dr Morhbacher. For further information visit http://www.HemOnc101.com
Dr. Talebi's practice, Miami Hematology and Oncology Associates is located at 151 NW 11th street, Suite W303. Homestead, Fl 33030. Tel 786-504-3084
Hodgkin lymphoma
Hodgkin lymphoma accounts for approximately 10 percent of all lymphomas and approximately 0.6 percent of all cancers diagnosed in the developed world annually. This amounts to approximately 8830 new cases and about 1300 deaths due to HL in the United States annually.
The majority of patients with classical Hodgkin lymphoma present with painless localized enlarged lymph nodes, typically involving the cervical (neck) region.
Hodgkin lymphoma arises from germinal center or post-germinal center B cells in the lymph nodes. Hodgkin lymphoma has a unique cellular composition, containing a minority of neoplastic cells (Reed-Sternberg cells and their variants) in an inflammatory background. It is separated from the other B cell lymphomas based on its unique clinicopathologic features, and can be divided into two major sub-groups, based on the appearance and immunophenotype of the tumor cells.
The diagnosis of Hodgkin lymphoma is made by the evaluation of involved tissue, usually a lymph node biopsy. Excisional biopsies are preferred and large core needle biopsies may be adequate in select cases.
Here, Dr. Tony Talebi discusses the general concepts of Hodgkin lymphoma with Dr. Ann Morhbacher, associate professor of medicine at the University of Southern California and a "top US doctor" as per US world news and world report magazine. The discussion includes symptoms, diagnosis, staging, genetic implications, secondary cancers and treatment of hodgkin lymphoma.
Dr. Ann Morhbacher credentials:
Title:
Associate Professor of Clinical Medicine
Locations:
University of Southern California (USC) Norris Comprehensive Cancer Center
Specialties:
Hematology and Oncology
Background:
Dr. Mohrbacher, a graduate of Harvard Medical School, is a devoted educator, researcher and medical practitioner. She has several hematology related research interests and activities, including bone marrow transplantation, and has received thousands of dollars in research grants. She has been published in a number of medical journals and has been invited to lecture on topics including Radioimmunotherapy of non-Hodgkin's lymphoma and B-cell targeted therapy of rheumatoid arthritis. Dr. Mohrbacher is a member of the Southern California Lymphoma Group and currently belongs to a number of university related committees, such as the Post-Graduate Education Committee and the Clinical Investigations Committee.
Education:
Harvard and Radcliffe Colleges, Boston, MA, B.A., 1983
Doctor of Medicine, Harvard Medical School, Boston, MA, 1987
Internships:
Brigham and Women's Hospital, Boston, MA, 1983 - 1984
Residencies:
Brigham and Women's Hospital (Internal Medicine), Boston, MA, 1987 - 1990
Fellowships:
Clinical Medicine Fellow, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 1990 - 1993
Clinical Oncology and Tumor Immunology Fellow, Dana-Farber Cancer Institute, Boston, MA, 1990 - 1993
Board Certification:
Medical Oncology
Internal Medicine
Professional Society Memberships:
Massachusetts Medical Society, 1985
American Society of Hematology, 1994
Southwest Oncology Group, 1994
Awards:
A.B. Magna Cum Laude, 1983
Harvard College Scholarship, 1983
ASCO career Development Award, 1995
Dr. Mohrbacher was voted a Top Doctor by Pasadena Magazine in 2011.


Deeter went from being enlisted in the army and on his way to Afghanistan as a 22 year old, to watching Sponge Bob Square Pants in a children's hospital after his diagnosis. Something's not right here...
#50states50stories #TeenCancerAmerica #tyacancer
One young person is diagnosed with cancer every hour. To see what you can do go to: https://www.teencanceramerica.org/donate/


At the start of his cancer treatment, a very complex spine surgery
was scheduled. The doctors opined that even if the spine surgery was
successful, Bhupendra may never be able to walk again. Bhupendra
remembers telling his mother that he didn’t want to be a ‘burden’ on
anyone. He didn’t want to be wheelchair bound for the rest of his
life.
His mother explained to him that he had always made his parents proud,
be it during his school days or career. He had always given them
many occasions to be joyful. And she was certain that in future too,
he would keep on giving them many chances to rejoice. Her loving
words pumped courage in Bhupendra’s bloodstream
Through this journey, Bhupendra lost much. Years were lost to
treatment, and he eventually also lost his complete eyesight. But
amazingly, all these setbacks did not deter him from his habit of
winning! He survived and is now living proof that even stage IV cancer can be defeated.
Watch this video to know more about his inspiring cancer journey and how he is truly a cancer winner!
'Suffering is Optional' : Bhupendra Tripathi | Story of a Non-Hodgkin’s Lymphoma Survivor Pt-1 : https://youtu.be/Xa9pns99L1s
#CancerSurvivor #SurvivorStories #NonHodgkinsLymphoma
#FightCancerWithOnco
If you, or a loved one, have been diagnosed with cancer recently, and have questions or require guidance on cancer care, download the Onco Cancer Care App today! https://onco-app.onco.com/8WPu/care
Available on AppStore and Google Play
Connect with us:
Call: 79965 79965
Website: https://onco.com/
Facebook: facebook.com/OncoDotCom/
Instagram: instagram.com/oncodotcom/
Twitter: twitter.com/OncoDotCom
Bhupendra Tripathi's YouTube Channel Link: https://www.youtube.com/user/btripathi81


Helen talks about her experience of being diagnosed and treated for Primary mediastinal large b-cell lymphoma (PMBL) when she was 20. Helen talks about her experience of chemotherapy and radiotherapy and about remission and recovery.
For more information visit www.lymphoma-action.org.uk
This video was reviewed in 2019.


[Oncoinfo – Istantanee di Oncologia: seguici su http://oncoinfo.it] The SWOG S1826 trial could change the treatment of classic Hodgkin lymphoma forever. Why and how? We asked Alex Francisco Herrera (Associate Professor, Division Of Lymphoma - City of Hope National Medical Center, Duarte) at ASCO 2023, in Chicago. He explained us how N-AVD improved PFS vs BV-AVD in pts with AS HL.